Study highlights major hurdles for multinational clinical trials in Europe
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Dec-2025 04:11 ET (30-Dec-2025 09:11 GMT/UTC)
A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on significant ethical, administrative, regulatory, and logistical (EARL) hurdles in delivering multinational randomized clinical trials. The research was the first to comprehensively quantify these barriers for an international platform trial and emphasizes the need for urgent improvements, particularly in preparing for future public health crises.
Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or cancer or autoimmune disorders, weigh heavily on human health—and experts anticipate their incidence is on the rise. A new study by investigators from Mass General Brigham identified a protein called WSTF that could be targeted to block chronic inflammation. Crucially, this strategy would not interfere with acute inflammation, allowing the immune system to continue responding appropriately to short-term threats, such as viral or bacterial infection. Results are published in Nature.
Reported for the first time, in JAMA Psychiatry, lead author Carla Rash, Ph.D. of UConn School of Medicine and co-researchers at the University of Vermont School of Medicine and Washington State University Medicine, pinpoint the most effective and evidence-based incentive dosage levels to use during Contingency Mangaement care: $128 per week for vouchers or $55 per week for prizes over 12 weeks or longer to effectively reduce stimulant and/or opioid use.
A study reveals that some mutations in blood stem cells might help protect against late-onset Alzheimer’s disease. A team led by researchers at Baylor College of Medicine discovered that both a mouse model and people carrying blood stem cells with mutations in the gene TET2, but not in the gene DNMT3A, had a lower risk for developing Alzheimer’s disease. Their study proposes a mechanism that can protect against the disease and opens new avenues for potential strategies to control the emergence and progression of this devastating condition.
A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the process that drives Barrett’s esophagus formation. This condition affects the lining of the esophagus – the tube that carries food from the mouth to the stomach – and increases the risk of developing esophageal adenocarcinoma, a serious and often deadly cancer.
The study reveals that two important genes involved in guiing and maintaining the identity of the esophagus and intestine, SOX2 and CDX2, are altered in Barrett’s esophagus. The findings not only deepen our understanding of how the disease develops but also open the door to new ways of identifying people at risk and potentially preventing the condition from progressing to cancer.
A study led by scientists at Brown University and the University of Massachusetts Amherst found that children with higher levels of triclosan in their bodies were more likely to have allergy-related health issues, with young boys appearing most affected.